# K993159: Maxim Knee System

- Pathway: 510(k) (Special)
- Applicant: Biomet, Inc.
- Decided: Oct 14, 1999 after 23 days
- Product code: JWH (Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer)
- Device class: 2
- Regulation: 21 CFR 888.3560
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
14 later devices descend from it; 3 cite it directly.
0 of 15 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Most influential descendants
- K122160: Vanguard XP Knee System (2013), 6 descendants of its own
- K171054: Biomet Knee Joint Replacement Prostheses (2017), 5 descendants of its own
- K181947: Persona Revision Knee System (2018), 4 descendants of its own
- K132873: Vanguard XP Knee System (2013), 3 descendants of its own
- K141407: Vanguard XP Femoral Component (Gen II)/Vanguard XP Femoral Trial (2014), 2 descendants of its own

## Indications for use
The Maxim Knee System is indicated for: 1) Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, and/or traumatic arthritis where one or more compartments are involved. 2) Correction of varus, valgus, or posttraumatic deformity. 3) Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous joint replacement procedure. This device is for use with bone cement

Source page: https://510kreport.com/device/K993159
Methodology: https://510kreport.com/methodology